Boston Scientific Corp., based in the United States, is a healthcare company with a medium risk rating score of 22.1. The company specializes in producing innovative and less invasive medical devices for a variety of medical procedures. Boston Scientific's products cover a range of healthcare areas including angioplasty, blood clot filtration, cardiac rhythm management, and more. With a focus on ESG factors, the company aims to provide sustainable and effective solutions to healthcare professionals worldwide. Foreign sales make up a significant portion of Boston Scientific's revenue stream.